Click below to read the press release of our sponsor, Facio Therapies,
announcing the completion of an exploratory study conducted by CHDR to evaluate the utility
of real-world data for monitoring the progression of FSHD and the impact
of FSHD on daily life. Not only does this study represent the very first effort in the FSHD field to ultimately discover clinical outcome measures based on
real-world patient data obtained with the use of digital technologies, it also further validates our CHDR MORE® wearables/home monitoring platform.
